May 6, 2016
This conference aimed to: (1) identify the various ways in which law and ethics intersect with the use of big data in health care and health research, particularly in the United States; (2) understand the way U.S. law (and potentially other legal systems) currently promotes or stands as an obstacle to these potential uses; (3) determine what might be learned from the legal and ethical treatment of uses of big data in other sectors and countries; and (4) examine potential solutions (industry best practices, common law, legislative, executive, domestic and international) for better use of big data in health care and health research in the U.S.
Panel 2, Overcoming the Downsides of Big Data:
- Efthimios Parasidis, Moritz College of Law, The Ohio State University - The Future of Pharmacovigilance: Big Data as Fraud Enabler and Fraud Detector
- Sharona Hoffman, Case Western Reserve University School of Law - Big Data and the Americans with Disabilities Act: Amending the Law to Cover Discrimination Based on Data-Driven Predictions of Future Illnesses
- Sarah Malanga, James E. Rogers College of Law, University of Arizona - Big Data Neglects Populations Most in Need of Medical and Public Health Research and Interventions
- Carmel Shachar, Health Law and Policy Clinic, Harvard Law School - Potential Roadblocks in Health Care Big Data Collection: Gobeille v. Liberty Mutual, ERISA, and All-Payer Claims Databases
- Moderator: I. Glenn Cohen, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School 2016 annual conference focused on “Big Data, Health Law, and Bioethics.” The conference was organized in collaboration with the Berkman Center for Internet & Society at Harvard University and the Health Ethics and Policy Lab, University of Zurich.
Learn more at petrieflom.law.harvard.edu/events/details/2016-annual-conference.